Spots Global Cancer Trial Database for Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
Official Title: A Phase 1, 2-Part Study to Evaluate the Effect of Food on Pharmacokinetics of Pelabresib (CPI-0610) and the Effect of Pelabresib on QTc in Patients With Advanced Malignancies
Study ID: NCT05391022
Interventions
Study Description
Brief Summary: Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Gabrail Cancer Center Research, Canton, Ohio, United States
Gettysburg Cancer Center, Gettysburg, Pennsylvania, United States
Start Mountain Region, West Valley City, Utah, United States
Hight Technology Hospital Medcenter, Batumi, , Georgia
K. Eristavi National Center of Experimental and Clinical Surgery, Tbilisi, , Georgia
Simon Khechinashvili University Hospital, Tbilisi, , Georgia
Barcelona HM Nou Delfos, Barcelona, , Spain
Madrid - FJD, Madrid, , Spain
START CIOCC Hospital HM Sanchinarro, Madrid, , Spain
Hospital Universitario Virgen del Rocío, Sevilla, , Spain
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
